Impact of Specific Beers Criteria Medications on Associations between Drug Exposure and Unplanned Hospitalisation in Elderly Patients Taking High-Risk Drugs: A Case-Time-Control Study in Western Australia
Background Certain broad medication classes have previously been associated with high rates of hospitalisation due to related adverse events in elderly Western Australians, based on clinical coding recorded on inpatient summaries. Similarly, some medications from the Beers Criteria, considered poten...
Saved in:
| Published in | Drugs & aging Vol. 31; no. 4; pp. 311 - 325 |
|---|---|
| Main Authors | , , , |
| Format | Journal Article |
| Language | English |
| Published |
Cham
Springer International Publishing
01.04.2014
Adis International Springer Nature B.V |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1170-229X 1179-1969 1179-1969 |
| DOI | 10.1007/s40266-014-0164-6 |
Cover
Loading…
| Abstract | Background
Certain broad medication classes have previously been associated with high rates of hospitalisation due to related adverse events in elderly Western Australians, based on clinical coding recorded on inpatient summaries. Similarly, some medications from the Beers Criteria, considered potentially inappropriate in older people, have been linked with an increased risk of unplanned hospitalisation in this population.
Objective
Our objective was to determine whether risk estimates of drug-related hospitalisations are altered in elderly patients taking ‘high-risk drugs’ (HRDs) when specific Beers potentially inappropriate medications (PIMS) are taken into consideration.
Methods
Using the pharmaceutical claims of 251,305 Western Australians aged ≥65 years (1993–2005) linked with other health data, we applied a case-time-control design to estimate odds ratios (ORs) for unplanned hospitalisations associated with anticoagulants, antirheumatics, opioids, corticosteroids and four major cardiovascular drug groups, from which attributable fractions (AFs), number and proportion of drug-related admissions were derived. The analysis was repeated, taking into account exposure to eight specific PIMs, and results were compared.
Results
A total of 1,899,699 index hospitalisations were involved. Of index subjects, 12–57 % were exposed to each HRD at the time of admission, although the proportions taking both an HRD and one of the selected PIMs were much lower (generally ≤2 %, but as high as 8 % for combinations involving temazepam and for most PIMs combined with hypertension drugs). Included PIMs (indomethacin, naproxen, temazepam, oxazepam, diazepam, digoxin, amiodarone and ferrous sulphate) all tended to increase ORs, AFs and drug-related hospitalisation estimates in HRD combinations, although this was less evident for opioids and corticosteroids. Indomethacin had the greatest overall impact on HRD ORs/AFs. Indomethacin (OR 1.40; 95 % confidence interval [CI] 1.27–1.54) and naproxen (OR 1.22; 1.14–1.31) were associated with higher risks of unplanned hospitalisation than other antirheumatics (overall OR 1.09; 1.06–1.12). Similarly, among cardiac rhythm regulators, amiodarone (OR 1.22; 1.13–1.32) was riskier than digoxin (OR 1.08; 1.04–1.13). For comparisons of drug-related hospitalisation estimates, temazepam yielded the greatest absolute increases, especially with hypertension drugs.
Conclusions
Indomethacin and temazepam should be prescribed cautiously in elderly patients, especially in drug combinations. Furthermore, it appears other antirheumatics should be favoured over indomethacin/naproxen and, in situations where both drugs may be appropriate, digoxin over amiodarone. Our methodology may help assess the safety of new medications in drug combinations in preliminary pharmacovigilance investigations. |
|---|---|
| AbstractList | Certain broad medication classes have previously been associated with high rates of hospitalisation due to related adverse events in elderly Western Australians, based on clinical coding recorded on inpatient summaries. Similarly, some medications from the Beers Criteria, considered potentially inappropriate in older people, have been linked with an increased risk of unplanned hospitalisation in this population. Our objective was to determine whether risk estimates of drug-related hospitalisations are altered in elderly patients taking 'high-risk drugs' (HRDs) when specific Beers potentially inappropriate medications (PIMS) are taken into consideration. Using the pharmaceutical claims of 251,305 Western Australians aged ≥65 years (1993-2005) linked with other health data, we applied a case-time-control design to estimate odds ratios (ORs) for unplanned hospitalisations associated with anticoagulants, antirheumatics, opioids, corticosteroids and four major cardiovascular drug groups, from which attributable fractions (AFs), number and proportion of drug-related admissions were derived. The analysis was repeated, taking into account exposure to eight specific PIMs, and results were compared. A total of 1,899,699 index hospitalisations were involved. Of index subjects, 12-57 % were exposed to each HRD at the time of admission, although the proportions taking both an HRD and one of the selected PIMs were much lower (generally ≤2 %, but as high as 8 % for combinations involving temazepam and for most PIMs combined with hypertension drugs). Included PIMs (indomethacin, naproxen, temazepam, oxazepam, diazepam, digoxin, amiodarone and ferrous sulphate) all tended to increase ORs, AFs and drug-related hospitalisation estimates in HRD combinations, although this was less evident for opioids and corticosteroids. Indomethacin had the greatest overall impact on HRD ORs/AFs. Indomethacin (OR 1.40; 95 % confidence interval [CI] 1.27-1.54) and naproxen (OR 1.22; 1.14-1.31) were associated with higher risks of unplanned hospitalisation than other antirheumatics (overall OR 1.09; 1.06-1.12). Similarly, among cardiac rhythm regulators, amiodarone (OR 1.22; 1.13-1.32) was riskier than digoxin (OR 1.08; 1.04-1.13). For comparisons of drug-related hospitalisation estimates, temazepam yielded the greatest absolute increases, especially with hypertension drugs. Indomethacin and temazepam should be prescribed cautiously in elderly patients, especially in drug combinations. Furthermore, it appears other antirheumatics should be favoured over indomethacin/naproxen and, in situations where both drugs may be appropriate, digoxin over amiodarone. Our methodology may help assess the safety of new medications in drug combinations in preliminary pharmacovigilance investigations. Certain broad medication classes have previously been associated with high rates of hospitalisation due to related adverse events in elderly Western Australians, based on clinical coding recorded on inpatient summaries. Similarly, some medications from the Beers Criteria, considered potentially inappropriate in older people, have been linked with an increased risk of unplanned hospitalisation in this population. Our objective was to determine whether risk estimates of drug-related hospitalisations are altered in elderly patients taking 'high-risk drugs' (HRDs) when specific Beers potentially inappropriate medications (PIMS) are taken into consideration. Using the pharmaceutical claims of 251,305 Western Australians aged ≥65 years (1993-2005) linked with other health data, we applied a case-time-control design to estimate odds ratios (ORs) for unplanned hospitalisations associated with anticoagulants, antirheumatics, opioids, corticosteroids and four major cardiovascular drug groups, from which attributable fractions (AFs), number and proportion of drug-related admissions were derived. The analysis was repeated, taking into account exposure to eight specific PIMs, and results were compared. A total of 1,899,699 index hospitalisations were involved. Of index subjects, 12-57 % were exposed to each HRD at the time of admission, although the proportions taking both an HRD and one of the selected PIMs were much lower (generally ≤2 %, but as high as 8 % for combinations involving temazepam and for most PIMs combined with hypertension drugs). Included PIMs (indomethacin, naproxen, temazepam, oxazepam, diazepam, digoxin, amiodarone and ferrous sulphate) all tended to increase ORs, AFs and drug-related hospitalisation estimates in HRD combinations, although this was less evident for opioids and corticosteroids. Indomethacin had the greatest overall impact on HRD ORs/AFs. Indomethacin (OR 1.40; 95 % confidence interval [CI] 1.27-1.54) and naproxen (OR 1.22; 1.14-1.31) were associated with higher risks of unplanned hospitalisation than other antirheumatics (overall OR 1.09; 1.06-1.12). Similarly, among cardiac rhythm regulators, amiodarone (OR 1.22; 1.13-1.32) was riskier than digoxin (OR 1.08; 1.04-1.13). For comparisons of drug-related hospitalisation estimates, temazepam yielded the greatest absolute increases, especially with hypertension drugs. Indomethacin and temazepam should be prescribed cautiously in elderly patients, especially in drug combinations. Furthermore, it appears other antirheumatics should be favoured over indomethacin/naproxen and, in situations where both drugs may be appropriate, digoxin over amiodarone. Our methodology may help assess the safety of new medications in drug combinations in preliminary pharmacovigilance investigations. Background Certain broad medication classes have previously been associated with high rates of hospitalisation due to related adverse events in elderly Western Australians, based on clinical coding recorded on inpatient summaries. Similarly, some medications from the Beers Criteria, considered potentially inappropriate in older people, have been linked with an increased risk of unplanned hospitalisation in this population. Objective Our objective was to determine whether risk estimates of drug-related hospitalisations are altered in elderly patients taking ‘high-risk drugs’ (HRDs) when specific Beers potentially inappropriate medications (PIMS) are taken into consideration. Methods Using the pharmaceutical claims of 251,305 Western Australians aged ≥65 years (1993–2005) linked with other health data, we applied a case-time-control design to estimate odds ratios (ORs) for unplanned hospitalisations associated with anticoagulants, antirheumatics, opioids, corticosteroids and four major cardiovascular drug groups, from which attributable fractions (AFs), number and proportion of drug-related admissions were derived. The analysis was repeated, taking into account exposure to eight specific PIMs, and results were compared. Results A total of 1,899,699 index hospitalisations were involved. Of index subjects, 12–57 % were exposed to each HRD at the time of admission, although the proportions taking both an HRD and one of the selected PIMs were much lower (generally ≤2 %, but as high as 8 % for combinations involving temazepam and for most PIMs combined with hypertension drugs). Included PIMs (indomethacin, naproxen, temazepam, oxazepam, diazepam, digoxin, amiodarone and ferrous sulphate) all tended to increase ORs, AFs and drug-related hospitalisation estimates in HRD combinations, although this was less evident for opioids and corticosteroids. Indomethacin had the greatest overall impact on HRD ORs/AFs. Indomethacin (OR 1.40; 95 % confidence interval [CI] 1.27–1.54) and naproxen (OR 1.22; 1.14–1.31) were associated with higher risks of unplanned hospitalisation than other antirheumatics (overall OR 1.09; 1.06–1.12). Similarly, among cardiac rhythm regulators, amiodarone (OR 1.22; 1.13–1.32) was riskier than digoxin (OR 1.08; 1.04–1.13). For comparisons of drug-related hospitalisation estimates, temazepam yielded the greatest absolute increases, especially with hypertension drugs. Conclusions Indomethacin and temazepam should be prescribed cautiously in elderly patients, especially in drug combinations. Furthermore, it appears other antirheumatics should be favoured over indomethacin/naproxen and, in situations where both drugs may be appropriate, digoxin over amiodarone. Our methodology may help assess the safety of new medications in drug combinations in preliminary pharmacovigilance investigations. Certain broad medication classes have previously been associated with high rates of hospitalisation due to related adverse events in elderly Western Australians, based on clinical coding recorded on inpatient summaries. Similarly, some medications from the Beers Criteria, considered potentially inappropriate in older people, have been linked with an increased risk of unplanned hospitalisation in this population.BACKGROUNDCertain broad medication classes have previously been associated with high rates of hospitalisation due to related adverse events in elderly Western Australians, based on clinical coding recorded on inpatient summaries. Similarly, some medications from the Beers Criteria, considered potentially inappropriate in older people, have been linked with an increased risk of unplanned hospitalisation in this population.Our objective was to determine whether risk estimates of drug-related hospitalisations are altered in elderly patients taking 'high-risk drugs' (HRDs) when specific Beers potentially inappropriate medications (PIMS) are taken into consideration.OBJECTIVEOur objective was to determine whether risk estimates of drug-related hospitalisations are altered in elderly patients taking 'high-risk drugs' (HRDs) when specific Beers potentially inappropriate medications (PIMS) are taken into consideration.Using the pharmaceutical claims of 251,305 Western Australians aged ≥65 years (1993-2005) linked with other health data, we applied a case-time-control design to estimate odds ratios (ORs) for unplanned hospitalisations associated with anticoagulants, antirheumatics, opioids, corticosteroids and four major cardiovascular drug groups, from which attributable fractions (AFs), number and proportion of drug-related admissions were derived. The analysis was repeated, taking into account exposure to eight specific PIMs, and results were compared.METHODSUsing the pharmaceutical claims of 251,305 Western Australians aged ≥65 years (1993-2005) linked with other health data, we applied a case-time-control design to estimate odds ratios (ORs) for unplanned hospitalisations associated with anticoagulants, antirheumatics, opioids, corticosteroids and four major cardiovascular drug groups, from which attributable fractions (AFs), number and proportion of drug-related admissions were derived. The analysis was repeated, taking into account exposure to eight specific PIMs, and results were compared.A total of 1,899,699 index hospitalisations were involved. Of index subjects, 12-57 % were exposed to each HRD at the time of admission, although the proportions taking both an HRD and one of the selected PIMs were much lower (generally ≤2 %, but as high as 8 % for combinations involving temazepam and for most PIMs combined with hypertension drugs). Included PIMs (indomethacin, naproxen, temazepam, oxazepam, diazepam, digoxin, amiodarone and ferrous sulphate) all tended to increase ORs, AFs and drug-related hospitalisation estimates in HRD combinations, although this was less evident for opioids and corticosteroids. Indomethacin had the greatest overall impact on HRD ORs/AFs. Indomethacin (OR 1.40; 95 % confidence interval [CI] 1.27-1.54) and naproxen (OR 1.22; 1.14-1.31) were associated with higher risks of unplanned hospitalisation than other antirheumatics (overall OR 1.09; 1.06-1.12). Similarly, among cardiac rhythm regulators, amiodarone (OR 1.22; 1.13-1.32) was riskier than digoxin (OR 1.08; 1.04-1.13). For comparisons of drug-related hospitalisation estimates, temazepam yielded the greatest absolute increases, especially with hypertension drugs.RESULTSA total of 1,899,699 index hospitalisations were involved. Of index subjects, 12-57 % were exposed to each HRD at the time of admission, although the proportions taking both an HRD and one of the selected PIMs were much lower (generally ≤2 %, but as high as 8 % for combinations involving temazepam and for most PIMs combined with hypertension drugs). Included PIMs (indomethacin, naproxen, temazepam, oxazepam, diazepam, digoxin, amiodarone and ferrous sulphate) all tended to increase ORs, AFs and drug-related hospitalisation estimates in HRD combinations, although this was less evident for opioids and corticosteroids. Indomethacin had the greatest overall impact on HRD ORs/AFs. Indomethacin (OR 1.40; 95 % confidence interval [CI] 1.27-1.54) and naproxen (OR 1.22; 1.14-1.31) were associated with higher risks of unplanned hospitalisation than other antirheumatics (overall OR 1.09; 1.06-1.12). Similarly, among cardiac rhythm regulators, amiodarone (OR 1.22; 1.13-1.32) was riskier than digoxin (OR 1.08; 1.04-1.13). For comparisons of drug-related hospitalisation estimates, temazepam yielded the greatest absolute increases, especially with hypertension drugs.Indomethacin and temazepam should be prescribed cautiously in elderly patients, especially in drug combinations. Furthermore, it appears other antirheumatics should be favoured over indomethacin/naproxen and, in situations where both drugs may be appropriate, digoxin over amiodarone. Our methodology may help assess the safety of new medications in drug combinations in preliminary pharmacovigilance investigations.CONCLUSIONSIndomethacin and temazepam should be prescribed cautiously in elderly patients, especially in drug combinations. Furthermore, it appears other antirheumatics should be favoured over indomethacin/naproxen and, in situations where both drugs may be appropriate, digoxin over amiodarone. Our methodology may help assess the safety of new medications in drug combinations in preliminary pharmacovigilance investigations. |
| Author | Emery, Jon D. Price, Sylvie D. Sanfilippo, Frank M. Holman, C. D’Arcy J. |
| Author_xml | – sequence: 1 givenname: Sylvie D. surname: Price fullname: Price, Sylvie D. email: sylvie.price@uwa.edu.au organization: School of Population Health (M431), The University of Western Australia – sequence: 2 givenname: C. D’Arcy J. surname: Holman fullname: Holman, C. D’Arcy J. organization: School of Population Health (M431), The University of Western Australia – sequence: 3 givenname: Frank M. surname: Sanfilippo fullname: Sanfilippo, Frank M. organization: School of Population Health (M431), The University of Western Australia – sequence: 4 givenname: Jon D. surname: Emery fullname: Emery, Jon D. organization: School of Primary, Aboriginal and Rural Health Care (M706), The University of Western Australia |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28322650$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/24615204$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kttu1DAQhiNURA_wANwgSwiJm4DtOE7C3TYsbKUiEN0K7iLHmSxuEzt4EsG-Iw-Fs7scVAkuLB_0_f_MeOY0OrLOQhQ9ZvQFozR7iYJyKWPKRFhSxPJedMJYVsSskMXR7kxjzovPx9Ep4g2lVHLOHkTHXEiWcipOoh8X_aD0SFxLrgbQpjWanAN4JKU3I3ijyDtojFajcRaJs2SB6LQ53GsYvwFY8tpPG7L8PjicPBBlG3Jth05ZCw1ZORzMqDqDOxExliy7Bny3JR_CC9gRyVrdGrshK7P5En80eLszxFdkQUqFEK9ND3Hp7OhdR67GqdnOLp8AQ4YhowlHH_zVw-h-qzqER4f9LLp-s1yXq_jy_duLcnEZayHSMdagZN02VKRNmxeK1jUImak8l6kElkmV8pbVOsvrJmuTRlNIirZOCxr-E3KRJWfR873v4N3XKWRR9QY1dKFgcBNWLGWBFWnGAvr0DnrjJm9DdhWTjOZJlnAZqCcHaqp7aKrBm175bfWrTwF4dgAUatW1Xllt8A-XJ5zLlAaO7TntHaKH9jfCaDXPTLWfmSrMTDXPTDUHz-5odGjX3Krwq6b7r5LvlRii2A34v4r7p-gnIKjXaA |
| CitedBy_id | crossref_primary_10_1177_2050312116632426 crossref_primary_10_1111_ijpp_12397 crossref_primary_10_1016_j_jamda_2017_02_001 crossref_primary_10_1097_MLR_0000000000000587 crossref_primary_10_1371_journal_pone_0146811 crossref_primary_10_1007_s00228_016_2051_z crossref_primary_10_1007_s40266_018_0516_8 crossref_primary_10_1080_01459740_2019_1642888 crossref_primary_10_1080_07370016_2017_1304144 crossref_primary_10_1007_s40801_015_0035_4 crossref_primary_10_1007_s00103_017_2654_2 crossref_primary_10_4338_ACI_2014_04_RA_0040 |
| Cites_doi | 10.2217/ahe.12.6 10.1016/j.gerinurse.2011.03.004 10.1111/j.1368-5031.2004.0088.x 10.1016/j.maturitas.2010.03.004 10.2165/00002512-200825010-00007 10.1016/j.ejim.2012.09.011 10.2146/ajhp060548 10.1001/archinte.1997.00440350031003 10.1111/j.1365-2125.2010.03694.x 10.1007/s00228-007-0422-1 10.1177/1062860605276679 10.2146/ajhp110084 10.1038/clpt.2008.214 10.1056/NEJMsa1103053 10.1111/j.1532-5415.2011.03497.x 10.1097/00001648-199807000-00016 10.1071/AH080766 10.1097/00001648-199505000-00010 10.1111/j.1467-842X.1999.tb01297.x 10.1001/archinte.163.22.2716 10.1023/A:1015570104121 10.7861/clinmedicine.5-1-19 10.1016/j.amjopharm.2011.10.004 10.1111/j.1365-2125.2006.02839.x 10.1111/j.1365-2125.2006.02809.x 10.1002/msj.20278 10.1097/01.mlr.0000182534.19832.83 10.1017/S0959259810000171 10.1097/00001648-199605000-00003 10.2165/11534400-000000000-00000 10.1345/aph.1P426 10.1016/j.amjopharm.2012.03.002 10.1093/intqhc/mzg085 10.1007/s11096-012-9642-2 10.1111/j.1365-2710.2009.01021.x 10.1176/appi.ajp.158.6.892 10.1007/s00508-009-1251-2 10.2146/ajhp040567 10.1146/annurev.me.36.020185.002225 10.1080/01621459.1989.10478874 10.1002/pds.3469 10.2165/00002512-200825040-00007 10.1136/bmj.39503.424653.80 10.2519/jospt.2005.35.6.356 10.2165/00129784-200606020-00002 10.2165/11538460-000000000-00000 10.1016/j.cger.2009.01.005 10.1001/archinte.1991.00400090107019 10.2165/00002018-200528120-00008 10.1007/BF03256929 10.2165/00002018-200730100-00009 10.1007/BF03319101 10.2165/11584850-000000000-00000 10.1002/j.1552-4604.1995.tb04050.x 10.1111/j.1365-2710.2008.00929.x 10.1111/j.1365-2710.2007.00793.x 10.1136/jech.2003.008466 10.1002/jppr19982817 10.1177/1060028013504904 10.2165/11631760-000000000-00000 10.1002/pds.3510 10.1111/j.1532-5415.2012.03923.x 10.1002/j.2055-2335.2009.tb00698.x 10.1016/j.pmn.2010.03.003 10.1007/s00228-012-1309-3 10.5694/j.1326-5377.2005.tb06698.x 10.1093/oxfordjournals.aje.a115073 |
| ContentType | Journal Article |
| Copyright | Springer International Publishing Switzerland 2014 2015 INIST-CNRS Copyright Wolters Kluwer Health Adis International Apr 2014 |
| Copyright_xml | – notice: Springer International Publishing Switzerland 2014 – notice: 2015 INIST-CNRS – notice: Copyright Wolters Kluwer Health Adis International Apr 2014 |
| DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 3V. 4T- 7RV 7X7 7XB 88E 88G 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ K9. KB0 M0S M1P M2M NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS PSYQQ Q9U 7X8 |
| DOI | 10.1007/s40266-014-0164-6 |
| DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Docstoc Nursing & Allied Health Database Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Health & Medical Collection Medical Database Psychology Database Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Psychology ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition Docstoc ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | ProQuest One Psychology MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1179-1969 |
| EndPage | 325 |
| ExternalDocumentID | 3459514331 24615204 28322650 10_1007_s40266_014_0164_6 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | Australia Western Australia Oceania |
| GeographicLocations_xml | – name: Western Australia |
| GroupedDBID | --- -EM -~X .GJ 04C 0R~ 199 29G 2JY 34G 36B 39C 3V. 4.4 406 53G 5GY 5RE 6I2 6PF 7RV 7X7 88E 8FI 8FJ 8R4 8R5 95. AAAUJ AACDK AADNT AAIAL AAIKX AAJKR AAKAS AANZL AARHV AASML AATNV AAWTL AAYQN AAYTO AAYZH ABAKF ABDBF ABDZT ABFTV ABIPD ABIVO ABJNI ABJOX ABKCH ABKMS ABKTR ABLLE ABPLI ABTKH ABTMW ABUWG ABWHX ABXPI ACAOD ACCOQ ACCUX ACDTI ACGFS ACMJI ACMLO ACOKC ACPIV ACREN ACZOJ ADBBV ADFRT ADFZG ADHHG ADJJI ADOJX ADQRH ADRFC ADURQ ADYOE ADZCM ADZKW AEBTG AEFQL AEJHL AEJRE AEMSY AENEX AEOHA AEPYU AESKC AEVLU AEXYK AEYRQ AFBBN AFKRA AFZKB AGAYW AGDGC AGQEE AGQMX AGRTI AHIZS AHMBA AHSBF AIAKS AIGIU AILAN AJRNO ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMXSW AMYLF ASPBG AVWKF AWSVR AXYYD AZFZN AZQEC A~4 BENPR BGNMA BKEYQ BMSDO BPHCQ BVXVI BYPQX CAG CCPQU COF CS3 DCUDU DNIVK DPUIP DWQXO EAP EBLON EBS ECF ECT ECV EIHBH EJD EMB EMK EMOBN ENC ESX EX3 F5P F8P FERAY FIGPU FLLZZ FNLPD FSGXE FYUFA GNUQQ HMCUK HZ~ IAO IEA IHR IMOTQ INH INR ITC IWAJR J-C JZLTJ LGEZI LLZTM LOTEE M1P M2M M4Y NADUK NAPCQ NQJWS NU0 NXXTH O9- OAC OPC OVD P2P PCD PQQKQ PROAC PSQYO PSYQQ Q2X ROL RSV RZALA SISQX SJN SJYHP SNPRN SNX SOHCF SOJ SPKJE SRMVM SSLCW SV3 TEORI TSG U5U U9L UG4 UKHRP UNMZH UTJUX VDBLX VFIZW W48 WAF WOW WQ9 YFH Z0Y ZMTXR ~JE AAYXX ABBRH ABDBE ABFSG ACMFV ACSTC AEZWR AFDZB AFHIU AFOHR AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT IQODW ABRTQ CGR CUY CVF ECM EIF NPM PJZUB PPXIY 4T- 7XB 8FK K9. PKEHL PQEST PQUKI PRINS Q9U 7X8 |
| ID | FETCH-LOGICAL-c445t-cea6bfd045df89a0bbe467a88656e176a52f1bc78bd7f3dc0e39fb590117e8473 |
| IEDL.DBID | 7X7 |
| ISSN | 1170-229X 1179-1969 |
| IngestDate | Fri Jul 11 07:29:16 EDT 2025 Fri Jul 25 03:12:50 EDT 2025 Mon Jul 21 05:50:26 EDT 2025 Wed Apr 02 07:15:06 EDT 2025 Tue Jul 01 04:20:28 EDT 2025 Thu Apr 24 23:11:47 EDT 2025 Fri Feb 21 02:29:08 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Keywords | Amiodarone Temazepam Ferrous Sulphate Digoxin Naproxen Human Drug Alcoholic beverage High risk Treatment Risk factor Exposure Hospitalization Review Case control study Elderly Beer |
| Language | English |
| License | http://www.springer.com/tdm CC BY 4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c445t-cea6bfd045df89a0bbe467a88656e176a52f1bc78bd7f3dc0e39fb590117e8473 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-General Information-1 content type line 14 ObjectType-Feature-3 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | http://hdl.handle.net/11343/216649 |
| PMID | 24615204 |
| PQID | 1610837326 |
| PQPubID | 32188 |
| PageCount | 15 |
| ParticipantIDs | proquest_miscellaneous_1510114571 proquest_journals_1610837326 pubmed_primary_24615204 pascalfrancis_primary_28322650 crossref_primary_10_1007_s40266_014_0164_6 crossref_citationtrail_10_1007_s40266_014_0164_6 springer_journals_10_1007_s40266_014_0164_6 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2014-04-01 |
| PublicationDateYYYYMMDD | 2014-04-01 |
| PublicationDate_xml | – month: 04 year: 2014 text: 2014-04-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Cham |
| PublicationPlace_xml | – name: Cham – name: Auckland – name: New Zealand |
| PublicationTitle | Drugs & aging |
| PublicationTitleAbbrev | Drugs Aging |
| PublicationTitleAlternate | Drugs Aging |
| PublicationYear | 2014 |
| Publisher | Springer International Publishing Adis International Springer Nature B.V |
| Publisher_xml | – name: Springer International Publishing – name: Adis International – name: Springer Nature B.V |
| References | Salvi, Marchetti, D’Angelo, Boemi, Lattanzio, Cherubini (CR9) 2012; 35 Price, Holman, Sanfilippo, Emery (CR28) 2014; 48 Beijer, De Blaey (CR2) 2002; 24 Wynne, Blagburn (CR4) 2010; 66 CR39 Greenland, Rothman, Lash, Rothman, Greenland, Lash (CR57) 2008 CR38 Johnell, Klarin (CR67) 2007; 30 Wright, Feblowitz, Phansalkar, Liu, Wilcox, Keohane (CR74) 2012; 69 Britt, Miller, Bayram (CR44) 2007; 36 Zhang, Holman, Preen, Brameld (CR26) 2007; 63 CR35 Levy, Marcus, Christen (CR13) 2010; 44 CR34 Birkett (CR51) 1988; 11 Mahmood, Malone, Skrepnek, Abarca, Armstrong, Murphy (CR65) 2007; 64 Bucsa, Farcas, Cazacu, Leucuta, Achimas-Cadariu, Mogosan (CR72) 2013; 24 Leone, Magro, Moretti, Cutroneo, Moschini, Motola (CR59) 2010; 33 Maio (CR7) 2005; 20 Nobili, Pasina, Tettamanti, Lucca, Riva, Marzona (CR68) 2009; 34 Roughead, Kalisch, Barratt, Gilbert (CR64) 2010; 70 English, Holman, Milne, Winter, Hulse, Codde (CR58) 1995 Lin, Wei (CR54) 1989; 84 Wang, Bohn, Glynn, Mogun, Avorn (CR85) 2001; 158 CR49 Milton, Hill-Smith, Jackson (CR6) 2008; 336 CR48 CR47 CR46 Pasina, Djade, Nobili, Tettamanti, Franchi, Salerno (CR60) 2013; 22 Shi, Morike, Klotz (CR5) 2008; 64 CR45 CR89 CR88 Runciman, Roughead, Semple, Adams (CR11) 2003; 15 CR43 Dimitrow, Airaksinen, Kivela, Lyles, Leikola (CR15) 2011; 59 CR42 Pariente, Dartigues, Benichou, Letenneur, Moore, Fourrier-Reglat (CR86) 2008; 25 CR41 CR40 Hines, Murphy (CR76) 2011; 9 Zetin (CR84) 2004; 58 Marcum, Hanlon (CR92) 2012; 10 Vitry (CR62) 2007; 63 Chang, Chan (CR14) 2010; 27 French, Chirikos, Spehar, Campbell, Means, Bulat (CR87) 2005; 28 Fokter, Mozina, Brvar (CR71) 2010; 122 Boparai, Korc-Grodzicki (CR3) 2011; 78 Secoli, Figueras, Lebrao, de Lima, Santos (CR69) 2010; 27 Quan, Sundararajan, Halfon, Fong, Burnand, Luthi (CR52) 2005; 43 Roughead, Gilbert, Primrose, Sansom (CR22) 1998; 28 Moura, Prado, Belo, Acurcio (CR61) 2012; 34 Gallagher, Barry, O’Mahony (CR20) 2007; 32 Tangiisuran, Gozzoli, Davies, Rajkumar (CR1) 2010; 20 Duckett (CR31) 2004; 25 Greenblatt (CR50) 1985; 36 CR53 Greenland, Rothman, Greenland, Lash (CR56) 2008 Budnitz, Lovegrove, Shehab, Richards (CR10) 2011; 365 Moura, Prado, Acurcio (CR66) 2011; 31 Dawes (CR24) 1994 Feely, Barry (CR83) 2005; 5 CR91 Suissa (CR29) 1995; 6 Obreli-Neto, Nobili, Oliveira Baldoni, Guidoni, Lyra Junior, Pilger (CR70) 2012; 68 (CR19) 2012; 60 Petrovic, Tv, Onder (CR8) 2012; 29 Biederman (CR78) 2005; 35 Malone, Hutchins, Haupert, Hansten, Duncan, Van Bergen (CR63) 2005; 62 Harris, Harris (CR33) 1998; 20 Arnstein (CR79) 2010; 11 Jelinek, Warner (CR82) 2011; 32 Burgess, Holman, Satti (CR25) 2005; 182 Tulner, Frankfort, Gijsen, van Campen, Koks, Beijnen (CR73) 2008; 25 Hodgkinson, Dirnbauer, Larmour (CR23) 2009; 39 Holman, Bass, Rosman, Smith, Semmens, Glasson (CR37) 2008; 32 Bauman, DiDomenico, Galanter (CR81) 2006; 6 Laroche, Charmes, Bouthier, Merle (CR12) 2009; 85 Fick, Cooper, Wade, Waller, Maclean, Beers (CR18) 2003; 163 Wawruch, Fialova, Zikavska, Wsolova, Jezova, Kuzelova (CR21) 2008; 33 Cooney, Pascuzzi (CR80) 2009; 25 Park, Qin, Bavry (CR77) 2012; 8 Price, Holman, Sanfilippo, Emery (CR27) 2013; 22 Greenland (CR90) 1996; 7 Beers (CR17) 1997; 157 Holman, Bass, Rouse, Hobbs (CR36) 1999; 23 Greenland, Robins (CR55) 1988; 128 Schafer (CR75) 1995; 35 Lopert (CR32) 2009; 60 Suissa (CR30) 1998; 9 Beers, Ouslander, Rollingher, Reuben, Brooks, Beck (CR16) 1991; 151 164_CR45 PS Wang (164_CR85) 2001; 158 164_CR89 164_CR46 164_CR47 164_CR48 164_CR49 EE Roughead (164_CR64) 2010; 70 MS Dimitrow (164_CR15) 2011; 59 L Pasina (164_CR60) 2013; 22 CB Chang (164_CR14) 2010; 27 EE Roughead (164_CR22) 1998; 28 M Mahmood (164_CR65) 2007; 64 WB Runciman (164_CR11) 2003; 15 164_CR91 JL Bauman (164_CR81) 2006; 6 LEP Hines (164_CR76) 2011; 9 MR Hodgkinson (164_CR23) 2009; 39 164_CR53 CL Burgess (164_CR25) 2005; 182 S-R Secoli (164_CR69) 2010; 27 A Pariente (164_CR86) 2008; 25 C Bucsa (164_CR72) 2013; 24 F Salvi (164_CR9) 2012; 35 B Tangiisuran (164_CR1) 2010; 20 ML Laroche (164_CR12) 2009; 85 164_CR19 JC Milton (164_CR6) 2008; 336 S Suissa (164_CR29) 1995; 6 S Greenland (164_CR55) 1988; 128 MH Beers (164_CR17) 1997; 157 S Greenland (164_CR56) 2008 AI Vitry (164_CR62) 2007; 63 AI Schafer (164_CR75) 1995; 35 V Maio (164_CR7) 2005; 20 H Quan (164_CR52) 2005; 43 M Zhang (164_CR26) 2007; 63 S Suissa (164_CR30) 1998; 9 AM Nobili (164_CR68) 2009; 34 HA Wynne (164_CR4) 2010; 66 H Britt (164_CR44) 2007; 36 ZA Marcum (164_CR92) 2012; 10 DC Malone (164_CR63) 2005; 62 K Johnell (164_CR67) 2007; 30 HB Levy (164_CR13) 2010; 44 J Feely (164_CR83) 2005; 5 M Wawruch (164_CR21) 2008; 33 164_CR28 RE Biederman (164_CR78) 2005; 35 SD Price (164_CR27) 2013; 22 LR Tulner (164_CR73) 2008; 25 CDJ Holman (164_CR37) 2008; 32 A Wright (164_CR74) 2012; 69 DS Budnitz (164_CR10) 2011; 365 S Greenland (164_CR57) 2008 164_CR70 164_CR8 M Zetin (164_CR84) 2004; 58 MH Beers (164_CR16) 1991; 151 DJ Birkett (164_CR51) 1988; 11 164_CR34 164_CR35 164_CR79 P Gallagher (164_CR20) 2007; 32 DJ Greenblatt (164_CR50) 1985; 36 164_CR38 SJ Duckett (164_CR31) 2004; 25 164_CR39 HF Jelinek (164_CR82) 2011; 32 VP Dawes (164_CR24) 1994 CDJ Holman (164_CR36) 1999; 23 S Shi (164_CR5) 2008; 64 R Lopert (164_CR32) 2009; 60 KE Park (164_CR77) 2012; 8 DY Lin (164_CR54) 1989; 84 C Moura (164_CR66) 2011; 31 S Greenland (164_CR90) 1996; 7 D Cooney (164_CR80) 2009; 25 DD French (164_CR87) 2005; 28 MK Boparai (164_CR3) 2011; 78 CS Moura (164_CR61) 2012; 34 DR English (164_CR58) 1995 MG Harris (164_CR33) 1998; 20 HJM Beijer (164_CR2) 2002; 24 DM Fick (164_CR18) 2003; 163 R Leone (164_CR59) 2010; 33 164_CR40 164_CR41 N Fokter (164_CR71) 2010; 122 164_CR42 164_CR43 164_CR88 17252082 - Aust Fam Physician. 2007 Jan-Feb;36(1-2):36-40 21600673 - Geriatr Nurs. 2011 Jul-Aug;32(4):263-9 17166171 - Br J Clin Pharmacol. 2007 Jun;63(6):709-14 11384896 - Am J Psychiatry. 2001 Jun;158(6):892-8 14994972 - Int J Clin Pract. 2004 Jan;58(1):58-68 22483163 - Am J Geriatr Pharmacother. 2012 Apr;10(2):151-9 16174833 - Am J Health Syst Pharm. 2005 Oct 1;62(19):1983-91 18980573 - Aust Health Rev. 2008 Nov;32(4):766-77 3057878 - Am J Epidemiol. 1988 Dec;128(6):1185-97 1888249 - Arch Intern Med. 1991 Sep;151(9):1825-32 23041466 - Eur J Intern Med. 2013 Jan;24(1):27-33 16020673 - Am J Med Qual. 2005 Jul-Aug;20(4):177-8 14662625 - Arch Intern Med. 2003 Dec 8-22;163(22):2716-24 23797984 - Pharmacoepidemiol Drug Saf. 2013 Nov;22(11):1159-70 20653678 - Br J Clin Pharmacol. 2010 Aug;70(2):252-7 16329716 - Drug Saf. 2005;28(12):1141-50 22644345 - Eur J Clin Pharmacol. 2012 Dec;68(12):1667-76 3994325 - Annu Rev Med. 1985;36:421-7 21748749 - Mt Sinai J Med. 2011 Jul-Aug;78(4):613-26 21087065 - Drugs Aging. 2010 Dec 1;27(12):947-57 18613856 - J Clin Pharm Ther. 2008 Aug;33(4):381-92 22078863 - Am J Geriatr Pharmacother. 2011 Dec;9(6):364-77 22642780 - Drugs Aging. 2012 Jun 1;29(6):453-62 16224307 - Med Care. 2005 Nov;43(11):1130-9 24396090 - Ann Pharmacother. 2014 Jan;48(1):6-16 9647910 - Epidemiology. 1998 Jul;9(4):441-5 20809665 - Drugs Aging. 2010 Sep 1;27(9):759-70 21344954 - Clin Drug Investig. 2011;31(5):309-16 22535491 - Int J Clin Pharm. 2012 Aug;34(4):547-52 18987619 - Clin Pharmacol Ther. 2009 Jan;85(1):94-7 8728434 - Epidemiology. 1996 May;7(3):231-9 22111719 - N Engl J Med. 2011 Nov 24;365(21):2002-12 22376048 - J Am Geriatr Soc. 2012 Apr;60(4):616-31 14660523 - Int J Qual Health Care. 2003 Dec;15 Suppl 1:i49-59 10338721 - J Health Hum Serv Adm. 1998 Spring;20(4):442-67 19583670 - J Clin Pharm Ther. 2009 Aug;34(4):377-86 16555861 - Am J Cardiovasc Drugs. 2006;6(2):77-86 19555869 - Clin Geriatr Med. 2009 May;25(2):221-33 21797829 - J Am Geriatr Soc. 2011 Aug;59(8):1521-30 15252064 - J Epidemiol Community Health. 2004 Aug;58(8):635-41 23446784 - Drug Saf. 2012 Jan;35 Suppl 1:29-45 10575763 - Aust N Z J Public Health. 1999 Oct;23(5):453-9 21081709 - Ann Pharmacother. 2010 Dec;44(12):1968-75 17381661 - J Clin Pharm Ther. 2007 Apr;32(2):113-21 15777140 - Med J Aust. 2005 Mar 21;182(6):267-70 20635825 - Drug Saf. 2010 Aug 1;33(8):667-75 17867728 - Drug Saf. 2007;30(10):911-8 19639714 - Issue Brief (Commonw Fund). 2009 Jul;60:1-13 15229996 - Health Care Financ Rev. 2004 Spring;25(3):55-67 17274789 - Br J Clin Pharmacol. 2007 Feb;63(2):163-70 20399044 - Maturitas. 2010 Jul;66(3):246-50 18361544 - Drugs Aging. 2008;25(4):343-55 7608308 - J Clin Pharmacol. 1995 Mar;35(3):209-19 7619931 - Epidemiology. 1995 May;6(3):248-53 18180915 - Eur J Clin Pharmacol. 2008 Feb;64(2):183-99 20213374 - Wien Klin Wochenschr. 2010 Feb;122(3-4):81-8 18184030 - Drugs Aging. 2008;25(1):61-70 20510845 - Pain Manag Nurs. 2010 Jun;11(2 Suppl):S11-22 15745192 - Clin Med (Lond). 2005 Jan-Feb;5(1):19-22 22261944 - Am J Health Syst Pharm. 2012 Feb 1;69(3):221-7 9236554 - Arch Intern Med. 1997 Jul 28;157(14):1531-6 24038765 - Pharmacoepidemiol Drug Saf. 2013 Oct;22(10):1054-60 16001907 - J Orthop Sports Phys Ther. 2005 Jun;35(6):356-67 18340075 - BMJ. 2008 Mar 15;336(7644):606-9 17617500 - Am J Health Syst Pharm. 2007 Jul 15;64(14):1500-5 12061133 - Pharm World Sci. 2002 Apr;24(2):46-54 |
| References_xml | – ident: CR45 – volume: 8 start-page: 167 issue: 2 year: 2012 end-page: 177 ident: CR77 article-title: Nonsteroidal anti-inflammatory drugs and their effects in the elderly publication-title: Aging Health doi: 10.2217/ahe.12.6 – ident: CR49 – ident: CR39 – volume: 32 start-page: 269 issue: 4 year: 2011 ident: CR82 article-title: Digoxin therapy in the elderly: pharmacokinetic considerations in nursing publication-title: Geriatr Nurs doi: 10.1016/j.gerinurse.2011.03.004 – volume: 58 start-page: 58 issue: 1 year: 2004 end-page: 68 ident: CR84 article-title: Psychopharmacohazardology: major hazards of the new generation of psychotherapeutic drugs publication-title: Int J Clin Pract doi: 10.1111/j.1368-5031.2004.0088.x – volume: 66 start-page: 246 issue: 3 year: 2010 end-page: 250 ident: CR4 article-title: Drug treatment in an ageing population: practical implications publication-title: Maturitas doi: 10.1016/j.maturitas.2010.03.004 – volume: 25 start-page: 61 issue: 1 year: 2008 end-page: 70 ident: CR86 article-title: Benzodiazepines and injurious falls in community dwelling elders publication-title: Drugs Aging doi: 10.2165/00002512-200825010-00007 – volume: 11 start-page: 57 issue: 3 year: 1988 end-page: 59 ident: CR51 article-title: Pharmacokinetics made easy 3: half-life publication-title: Aust Prescriber – volume: 24 start-page: 27 issue: 1 year: 2013 end-page: 33 ident: CR72 article-title: How many potential drug-drug interactions cause adverse drug reactions in hospitalized patients? publication-title: Eur J Intern Med doi: 10.1016/j.ejim.2012.09.011 – volume: 64 start-page: 1500 issue: 14 year: 2007 end-page: 1505 ident: CR65 article-title: Potential drug–drug interactions within Veterans Affairs medical centers publication-title: Am J Health Syst Pharm doi: 10.2146/ajhp060548 – ident: CR35 – volume: 29 start-page: 453 issue: 6 year: 2012 end-page: 62 ident: CR8 article-title: Adverse drug reactions in older people: detection and prevention publication-title: Drugs Aging – volume: 157 start-page: 1531 issue: 14 year: 1997 end-page: 1536 ident: CR17 article-title: Explicit criteria for determining potentially inappropriate medication use by the elderly—an update publication-title: Arch Intern Med doi: 10.1001/archinte.1997.00440350031003 – volume: 70 start-page: 252 issue: 2 year: 2010 end-page: 257 ident: CR64 article-title: Prevalence of potentially hazardous drug interactions amongst Australian veterans publication-title: Br J Clin Pharmacol doi: 10.1111/j.1365-2125.2010.03694.x – volume: 64 start-page: 183 issue: 2 year: 2008 end-page: 199 ident: CR5 article-title: The clinical implications of ageing for rational drug therapy publication-title: Eur J Clin Pharmacol doi: 10.1007/s00228-007-0422-1 – volume: 20 start-page: 177 issue: 4 year: 2005 end-page: 178 ident: CR7 article-title: The quality of prescribing for the elderly: a forgotten issue? publication-title: Am J Med Qual doi: 10.1177/1062860605276679 – volume: 20 start-page: 442 issue: 1 year: 1998 end-page: 467 ident: CR33 article-title: The Australian health system: continuity and change publication-title: J Health Hum Serv Adm – volume: 60 start-page: 1 year: 2009 end-page: 13 ident: CR32 article-title: Evidence-based decision-making within Australia’s Pharmaceutical Benefits Scheme publication-title: Issue Brief (Commonwealth Fund) – ident: CR42 – volume: 36 start-page: 36 issue: 1–2 year: 2007 end-page: 40 ident: CR44 article-title: The quality of data on general practice—a discussion of BEACH reliability and validity publication-title: Aust Fam Physician – ident: CR46 – volume: 69 start-page: 221 issue: 3 year: 2012 end-page: 227 ident: CR74 article-title: Preventability of adverse drug events involving multiple drugs using publicly available clinical decision support tools publication-title: Am J Health Syst Pharm doi: 10.2146/ajhp110084 – volume: 85 start-page: 94 issue: 1 year: 2009 end-page: 97 ident: CR12 article-title: Inappropriate medications in the elderly publication-title: Clin Pharmacol Ther doi: 10.1038/clpt.2008.214 – volume: 39 start-page: 19 issue: 1 year: 2009 end-page: 23 ident: CR23 article-title: Identification of adverse drug reactions using the ICD-10 Australian Modification clinical coding surveillance publication-title: J Pharm Pract Res – start-page: 283 year: 2008 end-page: 302 ident: CR56 article-title: Applications of stratified analysis methods publication-title: Modern epidemiology – volume: 365 start-page: 2002 issue: 21 year: 2011 end-page: 2012 ident: CR10 article-title: Emergency hospitalizations for adverse drug events in older Americans publication-title: N Engl J Med doi: 10.1056/NEJMsa1103053 – volume: 60 start-page: 616 issue: 4 year: 2012 ident: CR19 article-title: American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults publication-title: J Am Geriatr Soc – volume: 59 start-page: 1521 issue: 8 year: 2011 end-page: 1530 ident: CR15 article-title: Comparison of prescribing criteria to evaluate the appropriateness of drug treatment in individuals aged 65 and older: a systematic review publication-title: J Am Geriatr Soc doi: 10.1111/j.1532-5415.2011.03497.x – ident: CR88 – volume: 9 start-page: 441 issue: 4 year: 1998 end-page: 445 ident: CR30 article-title: The case-time-control design: further assumptions and conditions publication-title: Epidemiology doi: 10.1097/00001648-199807000-00016 – volume: 32 start-page: 766 issue: 4 year: 2008 end-page: 777 ident: CR37 article-title: A decade of data linkage in Western Australia: strategic design, applications and benefits of the WA data linkage system publication-title: Aust Health Rev doi: 10.1071/AH080766 – volume: 6 start-page: 248 issue: 3 year: 1995 end-page: 253 ident: CR29 article-title: The case-time-control design publication-title: Epidemiology doi: 10.1097/00001648-199505000-00010 – volume: 182 start-page: 267 issue: 6 year: 2005 end-page: 270 ident: CR25 article-title: Adverse drug reactions in older Australians, 1981–2002 publication-title: Med J Aust – volume: 23 start-page: 453 issue: 5 year: 1999 end-page: 459 ident: CR36 article-title: Population-based linkage of health records in Western Australia: development of a health services research linked database publication-title: Aust N Z J Publ Health doi: 10.1111/j.1467-842X.1999.tb01297.x – volume: 163 start-page: 2716 issue: 22 year: 2003 end-page: 2724 ident: CR18 article-title: Updating the Beers Criteria for potentially inappropriate medication use in older adults—results of a US consensus panel of experts publication-title: Arch Intern Med doi: 10.1001/archinte.163.22.2716 – volume: 24 start-page: 46 issue: 2 year: 2002 end-page: 54 ident: CR2 article-title: Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies publication-title: Pharm World Sci doi: 10.1023/A:1015570104121 – volume: 5 start-page: 19 issue: 1 year: 2005 end-page: 22 ident: CR83 article-title: Adverse drug interactions publication-title: Clin Med doi: 10.7861/clinmedicine.5-1-19 – volume: 22 start-page: 1054 issue: 10 year: 2013 end-page: 1060 ident: CR60 article-title: Drug-drug interactions in a cohort of hospitalized elderly patients publication-title: Pharmacoepidemiol Drug Saf – volume: 11 start-page: S11 issue: 2 year: 2010 end-page: 22 ident: CR79 article-title: Balancing analgesic efficacy with safety concerns in the older patient publication-title: Pain Manag Nurs – volume: 9 start-page: 364 issue: 6 year: 2011 end-page: 377 ident: CR76 article-title: Potentially harmful drug–drug interactions in the elderly: a review publication-title: Am J Geriatr Pharmacother doi: 10.1016/j.amjopharm.2011.10.004 – volume: 63 start-page: 163 issue: 2 year: 2007 end-page: 170 ident: CR26 article-title: Repeat adverse drug reactions causing hospitalization in older Australians: a population-based longitudinal study 1980–2003 publication-title: Br J Clin Pharmacol doi: 10.1111/j.1365-2125.2006.02839.x – ident: CR43 – ident: CR91 – ident: CR47 – volume: 63 start-page: 709 issue: 6 year: 2007 end-page: 714 ident: CR62 article-title: Comparative assessment of four drug interaction compendia publication-title: Br J Clin Pharmacol doi: 10.1111/j.1365-2125.2006.02809.x – volume: 78 start-page: 613 issue: 4 year: 2011 end-page: 626 ident: CR3 article-title: Prescribing for older adults publication-title: Mt Sinai J Med doi: 10.1002/msj.20278 – volume: 43 start-page: 1130 issue: 11 year: 2005 end-page: 1139 ident: CR52 article-title: Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data publication-title: Med Care doi: 10.1097/01.mlr.0000182534.19832.83 – ident: CR53 – ident: CR89 – volume: 20 start-page: 246 issue: 3 year: 2010 end-page: 259 ident: CR1 article-title: Adverse drug reactions in older people publication-title: Rev Clin Gerontol doi: 10.1017/S0959259810000171 – volume: 48 start-page: 6 issue: 1 year: 2014 ident: CR28 article-title: Association between potentially inappropriate medications from the Beers Criteria and the risk of unplanned hospitalization in elderly patients publication-title: Ann Pharmacother – volume: 128 start-page: 1185 issue: 6 year: 1988 end-page: 1197 ident: CR55 article-title: Conceptual problems in the definition and interpretation of attributable fractions publication-title: Am J Epidemiol – volume: 7 start-page: 231 issue: 3 year: 1996 end-page: 239 ident: CR90 article-title: Confounding and exposure trends in case crossover and case time-control designs publication-title: Epidemiology doi: 10.1097/00001648-199605000-00003 – volume: 33 start-page: 667 issue: 8 year: 2010 end-page: 675 ident: CR59 article-title: Identifying adverse drug reactions associated with drug–drug interactions: data mining of a spontaneous reporting database in Italy publication-title: Drug Saf doi: 10.2165/11534400-000000000-00000 – volume: 44 start-page: 1968 issue: 12 year: 2010 end-page: 1975 ident: CR13 article-title: Beyond the Beers Criteria: a comparative overview of explicit criteria publication-title: Ann Pharmacother doi: 10.1345/aph.1P426 – volume: 68 start-page: 1667 issue: 12 year: 2012 ident: CR70 article-title: Adverse drug reactions caused by drug-drug interactions in elderly outpatients: a prospective cohort study publication-title: Eur J Clin Pharmacol – ident: CR40 – volume: 10 start-page: 151 issue: 2 year: 2012 end-page: 159 ident: CR92 article-title: Commentary on the new American Geriatric Society Beers Criteria for potentially inappropriate medication use in older adults publication-title: Am J Geriatr Pharmacother doi: 10.1016/j.amjopharm.2012.03.002 – volume: 15 start-page: i49 issue: Supplement 1 year: 2003 end-page: i59 ident: CR11 article-title: Adverse drug events and medication errors in Australia publication-title: Int J Qual Health Care doi: 10.1093/intqhc/mzg085 – volume: 34 start-page: 547 issue: 4 year: 2012 end-page: 552 ident: CR61 article-title: Evaluation of drug-drug interaction screening software combined with pharmacist intervention publication-title: Int J Clin Pharm doi: 10.1007/s11096-012-9642-2 – volume: 34 start-page: 377 issue: 4 year: 2009 end-page: 386 ident: CR68 article-title: Potentially severe drug interactions in elderly outpatients: results of an observational study of an administrative prescription database publication-title: J Clin Pharm Ther doi: 10.1111/j.1365-2710.2009.01021.x – volume: 158 start-page: 892 issue: 6 year: 2001 end-page: 898 ident: CR85 article-title: Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fracture publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.158.6.892 – volume: 122 start-page: 81 issue: 3–4 year: 2010 end-page: 88 ident: CR71 article-title: Potential drug-drug interactions and admissions due to drug–drug interactions in patients treated in medical departments publication-title: Wien Klin Wochenschr doi: 10.1007/s00508-009-1251-2 – ident: CR48 – volume: 62 start-page: 1983 issue: 19 year: 2005 end-page: 1991 ident: CR63 article-title: Assessment of potential drug-drug interactions with a prescription claims database publication-title: Am J Health Syst Pharm doi: 10.2146/ajhp040567 – volume: 36 start-page: 421 year: 1985 end-page: 427 ident: CR50 article-title: Elimination half-life of drugs: value and limitations publication-title: Annu Rev Med doi: 10.1146/annurev.me.36.020185.002225 – volume: 25 start-page: 55 issue: 3 year: 2004 end-page: 67 ident: CR31 article-title: Drug policy down under: Australia’s Pharmaceutical Benefits Scheme publication-title: Health Care Financ Rev – ident: CR38 – volume: 84 start-page: 1074 issue: 408 year: 1989 end-page: 1078 ident: CR54 article-title: The robust inference for the Cox proportional hazards model publication-title: J Am Stat Assoc doi: 10.1080/01621459.1989.10478874 – volume: 28 start-page: 7 issue: 1 year: 1998 end-page: 12 ident: CR22 article-title: Coding drug-related admissions in medical records: is it adequate for monitoring the quality of medication use publication-title: Aust J Hosp Pharm – volume: 22 start-page: 1159 issue: 11 year: 2013 end-page: 1170 ident: CR27 article-title: Use of case-time-control design in pharmacovigilance applications: exploration with high-risk medications and unplanned hospital admissions in the Western Australian elderly publication-title: Pharmacoepidemiol Drug Saf doi: 10.1002/pds.3469 – ident: CR34 – volume: 25 start-page: 343 issue: 4 year: 2008 end-page: 355 ident: CR73 article-title: Drug–drug interactions in a geriatric outpatient cohort: prevalence and relevance publication-title: Drugs Aging doi: 10.2165/00002512-200825040-00007 – volume: 336 start-page: 606 issue: 7644 year: 2008 end-page: 609 ident: CR6 article-title: Prescribing for older people publication-title: Br Med J doi: 10.1136/bmj.39503.424653.80 – year: 1994 ident: CR24 publication-title: Poisoning in Western Australia: overview, and investigation of therapeutic poisoning in the elderly [MPH Thesis] – start-page: 6 year: 1995 end-page: 19 ident: CR58 publication-title: The quantification of drug caused morbidity and mortality in Australia 1995—part 1 – volume: 35 start-page: 356 issue: 6 year: 2005 end-page: 367 ident: CR78 article-title: Pharmacology in rehabilitation: nonsteroidal anti-inflammatory agents publication-title: J Orthop Sports Phys Ther doi: 10.2519/jospt.2005.35.6.356 – volume: 6 start-page: 77 issue: 2 year: 2006 end-page: 86 ident: CR81 article-title: Mechanisms, manifestations, and management of digoxin toxicity in the modern era publication-title: Am J Cardiovasc Drugs doi: 10.2165/00129784-200606020-00002 – volume: 27 start-page: 759 issue: 9 year: 2010 end-page: 770 ident: CR69 article-title: Risk of potential drug–drug interactions among Brazilian elderly: a population-based, cross-sectional study publication-title: Drugs Aging doi: 10.2165/11538460-000000000-00000 – volume: 25 start-page: 221 issue: 2 year: 2009 end-page: 233 ident: CR80 article-title: Polypharmacy in the elderly: focus on drug interactions and adherence in hypertension publication-title: Clin Geriatr Med doi: 10.1016/j.cger.2009.01.005 – volume: 151 start-page: 1825 issue: 9 year: 1991 end-page: 1832 ident: CR16 article-title: Explicit criteria for determining inappropriate medication use in nursing-home residents publication-title: Arch Intern Med doi: 10.1001/archinte.1991.00400090107019 – ident: CR41 – volume: 28 start-page: 1141 issue: 12 year: 2005 end-page: 1150 ident: CR87 article-title: Effect of concomitant use of benzodiazepines and other drugs on the risk of injury in a veterans population publication-title: Drug Saf doi: 10.2165/00002018-200528120-00008 – volume: 31 start-page: 309 issue: 5 year: 2011 end-page: 316 ident: CR66 article-title: Potential drug–drug interactions associated with prolonged stays in the intensive care unit: a retrospective cohort study publication-title: Clin Drug Invest doi: 10.1007/BF03256929 – volume: 30 start-page: 911 issue: 10 year: 2007 end-page: 918 ident: CR67 article-title: The relationship between number of drugs and potential drug–drug interactions in the elderly: a study of over 600 000 elderly patients from the Swedish prescribed drug register publication-title: Drug Saf doi: 10.2165/00002018-200730100-00009 – volume: 35 start-page: 29 issue: Suppl 1 year: 2012 end-page: 45 ident: CR9 article-title: Adverse drug events as a cause of hospitalization in older adults publication-title: Drug Saf doi: 10.1007/BF03319101 – volume: 27 start-page: 947 issue: 12 year: 2010 end-page: 957 ident: CR14 article-title: Comparison of published explicit criteria for potentially inappropriate medications in older adults publication-title: Drugs Aging doi: 10.2165/11584850-000000000-00000 – volume: 35 start-page: 209 issue: 3 year: 1995 end-page: 219 ident: CR75 article-title: Effects of nonsteroidal antiinflammatory drugs on platelet function and systemic hemostasis publication-title: J Clin Pharmacol doi: 10.1002/j.1552-4604.1995.tb04050.x – volume: 33 start-page: 381 issue: 4 year: 2008 end-page: 392 ident: CR21 article-title: Factors influencing the use of potentially inappropriate medication in older patients in Slovakia publication-title: J Clin Pharm Ther doi: 10.1111/j.1365-2710.2008.00929.x – volume: 32 start-page: 113 issue: 2 year: 2007 end-page: 121 ident: CR20 article-title: Inappropriate prescribing in the elderly publication-title: J Clin Pharm Ther doi: 10.1111/j.1365-2710.2007.00793.x – start-page: 51 year: 2008 end-page: 70 ident: CR57 article-title: Measures of effect and measures of association publication-title: Modern epidemiology – volume: 69 start-page: 221 issue: 3 year: 2012 ident: 164_CR74 publication-title: Am J Health Syst Pharm doi: 10.2146/ajhp110084 – ident: 164_CR47 – volume: 33 start-page: 381 issue: 4 year: 2008 ident: 164_CR21 publication-title: J Clin Pharm Ther doi: 10.1111/j.1365-2710.2008.00929.x – ident: 164_CR53 – volume: 151 start-page: 1825 issue: 9 year: 1991 ident: 164_CR16 publication-title: Arch Intern Med doi: 10.1001/archinte.1991.00400090107019 – ident: 164_CR43 – volume: 23 start-page: 453 issue: 5 year: 1999 ident: 164_CR36 publication-title: Aust N Z J Publ Health doi: 10.1111/j.1467-842X.1999.tb01297.x – ident: 164_CR88 doi: 10.1136/jech.2003.008466 – volume: 44 start-page: 1968 issue: 12 year: 2010 ident: 164_CR13 publication-title: Ann Pharmacother doi: 10.1345/aph.1P426 – ident: 164_CR89 – volume: 20 start-page: 177 issue: 4 year: 2005 ident: 164_CR7 publication-title: Am J Med Qual doi: 10.1177/1062860605276679 – volume: 63 start-page: 163 issue: 2 year: 2007 ident: 164_CR26 publication-title: Br J Clin Pharmacol doi: 10.1111/j.1365-2125.2006.02839.x – volume: 6 start-page: 77 issue: 2 year: 2006 ident: 164_CR81 publication-title: Am J Cardiovasc Drugs doi: 10.2165/00129784-200606020-00002 – volume: 6 start-page: 248 issue: 3 year: 1995 ident: 164_CR29 publication-title: Epidemiology doi: 10.1097/00001648-199505000-00010 – volume: 63 start-page: 709 issue: 6 year: 2007 ident: 164_CR62 publication-title: Br J Clin Pharmacol doi: 10.1111/j.1365-2125.2006.02809.x – ident: 164_CR38 – volume: 5 start-page: 19 issue: 1 year: 2005 ident: 164_CR83 publication-title: Clin Med doi: 10.7861/clinmedicine.5-1-19 – volume: 59 start-page: 1521 issue: 8 year: 2011 ident: 164_CR15 publication-title: J Am Geriatr Soc doi: 10.1111/j.1532-5415.2011.03497.x – ident: 164_CR34 – volume: 157 start-page: 1531 issue: 14 year: 1997 ident: 164_CR17 publication-title: Arch Intern Med doi: 10.1001/archinte.1997.00440350031003 – volume: 70 start-page: 252 issue: 2 year: 2010 ident: 164_CR64 publication-title: Br J Clin Pharmacol doi: 10.1111/j.1365-2125.2010.03694.x – ident: 164_CR91 – volume: 64 start-page: 183 issue: 2 year: 2008 ident: 164_CR5 publication-title: Eur J Clin Pharmacol doi: 10.1007/s00228-007-0422-1 – volume: 66 start-page: 246 issue: 3 year: 2010 ident: 164_CR4 publication-title: Maturitas doi: 10.1016/j.maturitas.2010.03.004 – volume: 27 start-page: 947 issue: 12 year: 2010 ident: 164_CR14 publication-title: Drugs Aging doi: 10.2165/11584850-000000000-00000 – ident: 164_CR48 – volume: 20 start-page: 246 issue: 3 year: 2010 ident: 164_CR1 publication-title: Rev Clin Gerontol doi: 10.1017/S0959259810000171 – volume: 30 start-page: 911 issue: 10 year: 2007 ident: 164_CR67 publication-title: Drug Saf doi: 10.2165/00002018-200730100-00009 – volume: 36 start-page: 36 issue: 1–2 year: 2007 ident: 164_CR44 publication-title: Aust Fam Physician – volume: 43 start-page: 1130 issue: 11 year: 2005 ident: 164_CR52 publication-title: Med Care doi: 10.1097/01.mlr.0000182534.19832.83 – volume: 122 start-page: 81 issue: 3–4 year: 2010 ident: 164_CR71 publication-title: Wien Klin Wochenschr doi: 10.1007/s00508-009-1251-2 – volume: 28 start-page: 7 issue: 1 year: 1998 ident: 164_CR22 publication-title: Aust J Hosp Pharm doi: 10.1002/jppr19982817 – volume: 33 start-page: 667 issue: 8 year: 2010 ident: 164_CR59 publication-title: Drug Saf doi: 10.2165/11534400-000000000-00000 – ident: 164_CR28 doi: 10.1177/1060028013504904 – volume: 28 start-page: 1141 issue: 12 year: 2005 ident: 164_CR87 publication-title: Drug Saf doi: 10.2165/00002018-200528120-00008 – volume: 36 start-page: 421 year: 1985 ident: 164_CR50 publication-title: Annu Rev Med doi: 10.1146/annurev.me.36.020185.002225 – volume: 9 start-page: 364 issue: 6 year: 2011 ident: 164_CR76 publication-title: Am J Geriatr Pharmacother doi: 10.1016/j.amjopharm.2011.10.004 – ident: 164_CR40 – start-page: 51 volume-title: Modern epidemiology year: 2008 ident: 164_CR57 – volume: 32 start-page: 766 issue: 4 year: 2008 ident: 164_CR37 publication-title: Aust Health Rev doi: 10.1071/AH080766 – ident: 164_CR8 doi: 10.2165/11631760-000000000-00000 – volume: 9 start-page: 441 issue: 4 year: 1998 ident: 164_CR30 publication-title: Epidemiology doi: 10.1097/00001648-199807000-00016 – volume: 22 start-page: 1054 issue: 10 year: 2013 ident: 164_CR60 publication-title: Pharmacoepidemiol Drug Saf doi: 10.1002/pds.3510 – volume: 27 start-page: 759 issue: 9 year: 2010 ident: 164_CR69 publication-title: Drugs Aging doi: 10.2165/11538460-000000000-00000 – ident: 164_CR19 doi: 10.1111/j.1532-5415.2012.03923.x – volume: 25 start-page: 343 issue: 4 year: 2008 ident: 164_CR73 publication-title: Drugs Aging doi: 10.2165/00002512-200825040-00007 – volume: 25 start-page: 61 issue: 1 year: 2008 ident: 164_CR86 publication-title: Drugs Aging doi: 10.2165/00002512-200825010-00007 – volume: 62 start-page: 1983 issue: 19 year: 2005 ident: 164_CR63 publication-title: Am J Health Syst Pharm doi: 10.2146/ajhp040567 – ident: 164_CR49 – volume: 39 start-page: 19 issue: 1 year: 2009 ident: 164_CR23 publication-title: J Pharm Pract Res doi: 10.1002/j.2055-2335.2009.tb00698.x – ident: 164_CR45 – volume: 8 start-page: 167 issue: 2 year: 2012 ident: 164_CR77 publication-title: Aging Health doi: 10.2217/ahe.12.6 – volume: 24 start-page: 46 issue: 2 year: 2002 ident: 164_CR2 publication-title: Pharm World Sci doi: 10.1023/A:1015570104121 – volume: 25 start-page: 55 issue: 3 year: 2004 ident: 164_CR31 publication-title: Health Care Financ Rev – volume: 35 start-page: 29 issue: Suppl 1 year: 2012 ident: 164_CR9 publication-title: Drug Saf doi: 10.1007/BF03319101 – start-page: 283 volume-title: Modern epidemiology year: 2008 ident: 164_CR56 – volume: 15 start-page: i49 issue: Supplement 1 year: 2003 ident: 164_CR11 publication-title: Int J Qual Health Care doi: 10.1093/intqhc/mzg085 – volume: 84 start-page: 1074 issue: 408 year: 1989 ident: 164_CR54 publication-title: J Am Stat Assoc doi: 10.1080/01621459.1989.10478874 – ident: 164_CR79 doi: 10.1016/j.pmn.2010.03.003 – volume: 20 start-page: 442 issue: 1 year: 1998 ident: 164_CR33 publication-title: J Health Hum Serv Adm – volume: 35 start-page: 356 issue: 6 year: 2005 ident: 164_CR78 publication-title: J Orthop Sports Phys Ther doi: 10.2519/jospt.2005.35.6.356 – volume: 163 start-page: 2716 issue: 22 year: 2003 ident: 164_CR18 publication-title: Arch Intern Med doi: 10.1001/archinte.163.22.2716 – volume: 365 start-page: 2002 issue: 21 year: 2011 ident: 164_CR10 publication-title: N Engl J Med doi: 10.1056/NEJMsa1103053 – volume: 24 start-page: 27 issue: 1 year: 2013 ident: 164_CR72 publication-title: Eur J Intern Med doi: 10.1016/j.ejim.2012.09.011 – ident: 164_CR41 – volume: 35 start-page: 209 issue: 3 year: 1995 ident: 164_CR75 publication-title: J Clin Pharmacol doi: 10.1002/j.1552-4604.1995.tb04050.x – volume: 85 start-page: 94 issue: 1 year: 2009 ident: 164_CR12 publication-title: Clin Pharmacol Ther doi: 10.1038/clpt.2008.214 – volume: 7 start-page: 231 issue: 3 year: 1996 ident: 164_CR90 publication-title: Epidemiology doi: 10.1097/00001648-199605000-00003 – volume: 10 start-page: 151 issue: 2 year: 2012 ident: 164_CR92 publication-title: Am J Geriatr Pharmacother doi: 10.1016/j.amjopharm.2012.03.002 – volume: 22 start-page: 1159 issue: 11 year: 2013 ident: 164_CR27 publication-title: Pharmacoepidemiol Drug Saf doi: 10.1002/pds.3469 – start-page: 6 volume-title: The quantification of drug caused morbidity and mortality in Australia 1995—part 1 year: 1995 ident: 164_CR58 – volume: 58 start-page: 58 issue: 1 year: 2004 ident: 164_CR84 publication-title: Int J Clin Pract doi: 10.1111/j.1368-5031.2004.0088.x – volume: 78 start-page: 613 issue: 4 year: 2011 ident: 164_CR3 publication-title: Mt Sinai J Med doi: 10.1002/msj.20278 – volume: 336 start-page: 606 issue: 7644 year: 2008 ident: 164_CR6 publication-title: Br Med J doi: 10.1136/bmj.39503.424653.80 – ident: 164_CR46 – volume-title: Poisoning in Western Australia: overview, and investigation of therapeutic poisoning in the elderly [MPH Thesis] year: 1994 ident: 164_CR24 – volume: 32 start-page: 113 issue: 2 year: 2007 ident: 164_CR20 publication-title: J Clin Pharm Ther doi: 10.1111/j.1365-2710.2007.00793.x – volume: 34 start-page: 547 issue: 4 year: 2012 ident: 164_CR61 publication-title: Int J Clin Pharm doi: 10.1007/s11096-012-9642-2 – volume: 25 start-page: 221 issue: 2 year: 2009 ident: 164_CR80 publication-title: Clin Geriatr Med doi: 10.1016/j.cger.2009.01.005 – volume: 34 start-page: 377 issue: 4 year: 2009 ident: 164_CR68 publication-title: J Clin Pharm Ther doi: 10.1111/j.1365-2710.2009.01021.x – volume: 32 start-page: 269 issue: 4 year: 2011 ident: 164_CR82 publication-title: Geriatr Nurs doi: 10.1016/j.gerinurse.2011.03.004 – volume: 158 start-page: 892 issue: 6 year: 2001 ident: 164_CR85 publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.158.6.892 – volume: 60 start-page: 1 year: 2009 ident: 164_CR32 publication-title: Issue Brief (Commonwealth Fund) – ident: 164_CR70 doi: 10.1007/s00228-012-1309-3 – volume: 182 start-page: 267 issue: 6 year: 2005 ident: 164_CR25 publication-title: Med J Aust doi: 10.5694/j.1326-5377.2005.tb06698.x – ident: 164_CR39 – volume: 128 start-page: 1185 issue: 6 year: 1988 ident: 164_CR55 publication-title: Am J Epidemiol doi: 10.1093/oxfordjournals.aje.a115073 – ident: 164_CR35 – ident: 164_CR42 – volume: 64 start-page: 1500 issue: 14 year: 2007 ident: 164_CR65 publication-title: Am J Health Syst Pharm doi: 10.2146/ajhp060548 – volume: 31 start-page: 309 issue: 5 year: 2011 ident: 164_CR66 publication-title: Clin Drug Invest doi: 10.1007/BF03256929 – volume: 11 start-page: 57 issue: 3 year: 1988 ident: 164_CR51 publication-title: Aust Prescriber – reference: 20510845 - Pain Manag Nurs. 2010 Jun;11(2 Suppl):S11-22 – reference: 22078863 - Am J Geriatr Pharmacother. 2011 Dec;9(6):364-77 – reference: 11384896 - Am J Psychiatry. 2001 Jun;158(6):892-8 – reference: 7608308 - J Clin Pharmacol. 1995 Mar;35(3):209-19 – reference: 19639714 - Issue Brief (Commonw Fund). 2009 Jul;60:1-13 – reference: 10575763 - Aust N Z J Public Health. 1999 Oct;23(5):453-9 – reference: 14662625 - Arch Intern Med. 2003 Dec 8-22;163(22):2716-24 – reference: 18987619 - Clin Pharmacol Ther. 2009 Jan;85(1):94-7 – reference: 22535491 - Int J Clin Pharm. 2012 Aug;34(4):547-52 – reference: 17617500 - Am J Health Syst Pharm. 2007 Jul 15;64(14):1500-5 – reference: 3994325 - Annu Rev Med. 1985;36:421-7 – reference: 7619931 - Epidemiology. 1995 May;6(3):248-53 – reference: 22483163 - Am J Geriatr Pharmacother. 2012 Apr;10(2):151-9 – reference: 24038765 - Pharmacoepidemiol Drug Saf. 2013 Oct;22(10):1054-60 – reference: 22644345 - Eur J Clin Pharmacol. 2012 Dec;68(12):1667-76 – reference: 18340075 - BMJ. 2008 Mar 15;336(7644):606-9 – reference: 22642780 - Drugs Aging. 2012 Jun 1;29(6):453-62 – reference: 21087065 - Drugs Aging. 2010 Dec 1;27(12):947-57 – reference: 3057878 - Am J Epidemiol. 1988 Dec;128(6):1185-97 – reference: 20635825 - Drug Saf. 2010 Aug 1;33(8):667-75 – reference: 18361544 - Drugs Aging. 2008;25(4):343-55 – reference: 17274789 - Br J Clin Pharmacol. 2007 Feb;63(2):163-70 – reference: 10338721 - J Health Hum Serv Adm. 1998 Spring;20(4):442-67 – reference: 16224307 - Med Care. 2005 Nov;43(11):1130-9 – reference: 14994972 - Int J Clin Pract. 2004 Jan;58(1):58-68 – reference: 21797829 - J Am Geriatr Soc. 2011 Aug;59(8):1521-30 – reference: 18613856 - J Clin Pharm Ther. 2008 Aug;33(4):381-92 – reference: 21344954 - Clin Drug Investig. 2011;31(5):309-16 – reference: 19583670 - J Clin Pharm Ther. 2009 Aug;34(4):377-86 – reference: 17252082 - Aust Fam Physician. 2007 Jan-Feb;36(1-2):36-40 – reference: 21081709 - Ann Pharmacother. 2010 Dec;44(12):1968-75 – reference: 12061133 - Pharm World Sci. 2002 Apr;24(2):46-54 – reference: 22376048 - J Am Geriatr Soc. 2012 Apr;60(4):616-31 – reference: 9647910 - Epidemiology. 1998 Jul;9(4):441-5 – reference: 19555869 - Clin Geriatr Med. 2009 May;25(2):221-33 – reference: 23797984 - Pharmacoepidemiol Drug Saf. 2013 Nov;22(11):1159-70 – reference: 16555861 - Am J Cardiovasc Drugs. 2006;6(2):77-86 – reference: 20809665 - Drugs Aging. 2010 Sep 1;27(9):759-70 – reference: 24396090 - Ann Pharmacother. 2014 Jan;48(1):6-16 – reference: 16329716 - Drug Saf. 2005;28(12):1141-50 – reference: 15745192 - Clin Med (Lond). 2005 Jan-Feb;5(1):19-22 – reference: 22261944 - Am J Health Syst Pharm. 2012 Feb 1;69(3):221-7 – reference: 20653678 - Br J Clin Pharmacol. 2010 Aug;70(2):252-7 – reference: 17166171 - Br J Clin Pharmacol. 2007 Jun;63(6):709-14 – reference: 21600673 - Geriatr Nurs. 2011 Jul-Aug;32(4):263-9 – reference: 23446784 - Drug Saf. 2012 Jan;35 Suppl 1:29-45 – reference: 20399044 - Maturitas. 2010 Jul;66(3):246-50 – reference: 14660523 - Int J Qual Health Care. 2003 Dec;15 Suppl 1:i49-59 – reference: 8728434 - Epidemiology. 1996 May;7(3):231-9 – reference: 18184030 - Drugs Aging. 2008;25(1):61-70 – reference: 15252064 - J Epidemiol Community Health. 2004 Aug;58(8):635-41 – reference: 16001907 - J Orthop Sports Phys Ther. 2005 Jun;35(6):356-67 – reference: 15777140 - Med J Aust. 2005 Mar 21;182(6):267-70 – reference: 21748749 - Mt Sinai J Med. 2011 Jul-Aug;78(4):613-26 – reference: 16174833 - Am J Health Syst Pharm. 2005 Oct 1;62(19):1983-91 – reference: 16020673 - Am J Med Qual. 2005 Jul-Aug;20(4):177-8 – reference: 18980573 - Aust Health Rev. 2008 Nov;32(4):766-77 – reference: 17381661 - J Clin Pharm Ther. 2007 Apr;32(2):113-21 – reference: 1888249 - Arch Intern Med. 1991 Sep;151(9):1825-32 – reference: 15229996 - Health Care Financ Rev. 2004 Spring;25(3):55-67 – reference: 18180915 - Eur J Clin Pharmacol. 2008 Feb;64(2):183-99 – reference: 20213374 - Wien Klin Wochenschr. 2010 Feb;122(3-4):81-8 – reference: 23041466 - Eur J Intern Med. 2013 Jan;24(1):27-33 – reference: 9236554 - Arch Intern Med. 1997 Jul 28;157(14):1531-6 – reference: 22111719 - N Engl J Med. 2011 Nov 24;365(21):2002-12 – reference: 17867728 - Drug Saf. 2007;30(10):911-8 |
| SSID | ssj0006221 |
| Score | 2.1361077 |
| Snippet | Background
Certain broad medication classes have previously been associated with high rates of hospitalisation due to related adverse events in elderly Western... Certain broad medication classes have previously been associated with high rates of hospitalisation due to related adverse events in elderly Western... |
| SourceID | proquest pubmed pascalfrancis crossref springer |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 311 |
| SubjectTerms | Adrenal Cortex Hormones - adverse effects Aged Amiodarone - adverse effects Analgesics, Opioid - adverse effects Anticoagulants Anticoagulants - adverse effects Antirheumatic Agents - adverse effects Biological and medical sciences Cardiovascular Agents - adverse effects Case-Control Studies Digoxin - adverse effects Estimates Female Geriatrics/Gerontology Hospitalization Hospitalization - statistics & numerical data Humans Hypertension Inappropriate Prescribing - statistics & numerical data Indomethacin - adverse effects Internal Medicine Male Medical sciences Medicine Medicine & Public Health Naproxen - adverse effects Narcotics Odds Ratio Older people Original Research Article Patient admissions Pharmaceuticals Pharmacology. Drug treatments Pharmacology/Toxicology Pharmacotherapy Prescription drugs Steroids Temazepam - adverse effects Western Australia - epidemiology |
| Title | Impact of Specific Beers Criteria Medications on Associations between Drug Exposure and Unplanned Hospitalisation in Elderly Patients Taking High-Risk Drugs: A Case-Time-Control Study in Western Australia |
| URI | https://link.springer.com/article/10.1007/s40266-014-0164-6 https://www.ncbi.nlm.nih.gov/pubmed/24615204 https://www.proquest.com/docview/1610837326 https://www.proquest.com/docview/1510114571 |
| Volume | 31 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bi9NAFB50F0QQ0fUWXcsRZB90g7lMJqkv0taWVdhSlhb7FjKTGSkuSd20YP-jP8pzJpfuou5THpIMIfOdM9_MuXyMvVU88pQSwg0V5y7PDHczGRg0vAStKYtE31a5nk_F2YJ_XUbL5sCtatIqW59oHXVeKjoj_4DMBNlCjGzj0_qnS6pRFF1tJDTuskNqXUabr3jZbbg8EdR1VySuEgT9ZRvVpNI53DcJ2ktTDobgrrixLj1YZxX-IlNrW_yLfP4VOLXr0eQRe9gQSRjUM_-Y3dHFEbt33oTKj9jJrG5KvTuF-b7GqjqFE5jt21XvnrDfX2yhJJQGrBi9WSkYamSFQDIIBFCoozkWoVAWcG1KK2gSveDz1fY7jH-tSzpyhKzIYVGsSRFJ59CKkzSpQ7AqYEzq4Jc7mNV9XSuYW1ksoLwT92JV_bADVh9hACNcaF0qVXFHdV49UPLjjkb5Vvd5gO7E5ilbTMbz0ZnbaDy4iI1o4yqdCWlyJJa5SfqZJ6VG150lCfJM7cciiwLjSxUnMo9NmCtPh30jbcFsrHFlDZ-xg6Is9AsGuHnk_URrRQVafq4yPzZSBzii1F4oE4d57QynqmmATjocl2nXutmCIkVQpASKVDjsXffKuu7-cdvDvRuw6d4gNagAmbDDjlscpY2nqNI9rh32pruNNk6Bm6zQ5RafIcfp8yj2Hfa8xt9-cI6cNPC4w963gLw2-P--9eXtn_KK3Q-saZB1HLODzdVWv0bytZE9a2E9djiYDIdTvA7H09nFH3sOML4 |
| linkProvider | ProQuest |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1tb9MwELbGkAAJIRhvgTEOCfYBZpGkiZMiITS6Ti1bpwpa0W8hThw0MSVhaQX9U_wSfhR3dpJuAvZtn-OcLPnu_Jzv5WHseeL5dpIIwTuJ53EvzjweSzdDwwvRmmJfdHWX6-hIDKbeh5k_W2O_ml4YKqtsfKJ21GmR0Bv5a0QmiBYCRBvvyu-cWKMou9pQaBi1OFDLHxiyVW-He3i-L1x3vz_pDXjNKsBxN_6cJyoWMksRyqRZ2I1tKRU6izgMEdkoJxCx72aOTIJQpkHWSRNbdbqZ1C2agUJf3kG5V9hVvHhtKiEMZm2AZwvX9HkRmYvrdmdNFpVa9TBOExS7U82H8Lg4dw_eLOMKjyQzXBr_Art_JWr1_bd_m92qgSvsGk27w9ZUvsGujerU_AbbHpsh2MsdmKx6uqod2Ibxajz28i77PdSNmVBk8KlUuiQQ3itEoUC0C2QQYLJH2iKgyOGMClVQF5bB3uniK_R_lgU9cUKcpzDNS2JgUik0ZCh1qRIc59AnNvKTJYzNHNkKJpqGC6jOhX88rr5pgdUb2IUeXuycWmN4z9TxAxVbLknKZzNXAtoXontseimnf5-t50WuHjLAYNXrhkol1BDmpEnsBJlULkqUyu7I0GJ2c8JRUg9cJ96Pk6gdFa2VIkKliEgpImGxl-0vpZk2ctHirXNq0_5B7FMuIm-LbTZ6FNWeqYpWdmSxZ-1n9CmUKIpzVSxwDTlqx_MDx2IPjP6thHuIgV3bs9irRiHPCP_fXh9dvJWn7PpgMjqMDodHB4_ZDVebCVnKJlufny7UEwR-c7mlrQ3Yl8s27z_VoGuN |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ba9RAFB5qhSKIaL1Faz2C9kEbmsvkJojUvdC1tiy6i_sWM8mMFEsSm110_5q_wR_lOZPLtqh963OSw8Cc78w3OZePsecp96w09X3TTTk3eaK4mQhHIfBCRFPi-ZHucj069g-m_P3Mm62xX20vDJVVtjFRB-qsSOkf-R4yE2QLAbKNPdWURYz7w7fld5MUpCjT2spp1C5yKJc_8PpWvRn1ca9fOM5wMOkdmI3CgIkr8-ZmKhNfqAxpTabCKLGEkBg4kjBEliPtwE88R9kiDUKRBcrNUku6kRK6XTOQGNddtHuNXQ9cPDYRS8Gsu-xZvlP3fJGwi-NEszajSm17eGfz6R5P9R8-N_0LZ-LNMqlwe1Stq_Ev4vtX0lafhcPb7FZDYmG_9ro7bE3mm2zjqEnTb7KdcT0Qe7kLk1V_V7ULOzBejcpe3mW_R7pJEwoFn0qpywPhnURGCiTBQOCAOpOk0QFFDufcqYKmyAz6Z4uvMPhZFvS7E5I8g2lekhqTzKAVRmnKluAkhwEpk58uYVzPlK1goiW5gGpezI8n1TdtsHoN-9DDQ96kNhmzV9f0AxVeLsnK53rGBHR_i-6x6ZXs_n22nhe5fMgAL648CqVMqTnMztLEDpSQDloU0nJFaDCr3eE4bYavkwbIadyNjdZOEaNTxOQUsW-wl90nZT155LKXty-4TfcFKVE5yMINttX6UdxEqSpeYcpgz7rHGF8oaZTksljgOxS0be4FtsEe1P63Ms6RDzsWN9ir1iHPGf_fWh9dvpSnbAOBHX8YHR8-ZjccjRICyhZbn58t5BPkgHOxrcEG7MtVo_sPzXRvww |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Impact+of+Specific+Beers+Criteria+Medications+on+Associations+between+Drug+Exposure+and+Unplanned+Hospitalisation+in+Elderly+Patients+Taking+High-Risk+Drugs%3A+A+Case-Time-Control+Study+in+Western+Australia&rft.jtitle=Drugs+%26+aging&rft.au=Price%2C+Sylvie+D.&rft.au=Holman%2C+C.+D%E2%80%99Arcy+J.&rft.au=Sanfilippo%2C+Frank+M.&rft.au=Emery%2C+Jon+D.&rft.date=2014-04-01&rft.issn=1170-229X&rft.eissn=1179-1969&rft.volume=31&rft.issue=4&rft.spage=311&rft.epage=325&rft_id=info:doi/10.1007%2Fs40266-014-0164-6&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s40266_014_0164_6 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1170-229X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1170-229X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1170-229X&client=summon |